These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 1719729

  • 1. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
    Kiesewetter H, Jung F, Blume J, Spitzer S, Birk A.
    Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
    [Abstract] [Full Text] [Related]

  • 2. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
    Kiesewetter H, Blume J, Jung F, Spitzer S, Gerhards M, Waldhausen P, Wenzel E.
    Wien Med Wochenschr; 1989 Sep 15; 139(17):396-401. PubMed ID: 2480029
    [Abstract] [Full Text] [Related]

  • 3. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
    Költringer P, Langsteger W, Lind P, Klima G, Pierer G, Reisecker F, Eber O.
    Acta Med Austriaca; 1991 Sep 15; 18 Suppl 1():20-2. PubMed ID: 1719728
    [Abstract] [Full Text] [Related]

  • 4. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
    Költringer P, Langsteger W, Lind P, Klima G, Pierer G, Reisecker F, Eber O.
    Acta Med Austriaca; 1991 Sep 15; 18 Suppl 1():45-7. PubMed ID: 1719731
    [Abstract] [Full Text] [Related]

  • 5. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
    Koscielny J, Latza R, Pruss A, Kiesewetter H, Jung F, Meier C, Schimetta W.
    Clin Hemorheol Microcirc; 2000 Sep 15; 22(1):53-65. PubMed ID: 10711822
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
    Kiesewetter H, Blume J, Jung F, Spitzer S, Bach R, Birk A, Schieffer H, Wenzel E.
    Schweiz Med Wochenschr; 1989 Dec 23; 119(51):1862-7. PubMed ID: 2481883
    [Abstract] [Full Text] [Related]

  • 8. [Effect of stepwise hypervolemic versus isovolemic hemodilution in patients with intermittent claudication on muscle oxygen pressure during exercise].
    Höffkes HG, Saeger-Lorenz K, Ehrly AM.
    Vasa; 1991 Dec 23; 20(2):109-18. PubMed ID: 1877329
    [Abstract] [Full Text] [Related]

  • 9. [Hemodilution in peripheral arterial occlusive disease].
    Becsi C, Wehofer D, Weidinger P.
    Vasa Suppl; 1988 Dec 23; 26():113-5. PubMed ID: 2462284
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
    Pöhlmann G, Braumann A, Grohmann G.
    Vasa Suppl; 1991 Dec 23; 32():342-4. PubMed ID: 1722914
    [No Abstract] [Full Text] [Related]

  • 15. Hematocrit dependent changes of muscle tissue oxygen supply in the lower limb muscle of patients with intermittent claudication.
    Höffkes HG, Ehrly AM.
    Vasa; 1992 Dec 23; 21(4):350-4. PubMed ID: 1485467
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran].
    Ernst E, Kollar L, Matrai A.
    Acta Med Austriaca; 1991 Dec 23; 18 Suppl 1():27-9. PubMed ID: 1719730
    [Abstract] [Full Text] [Related]

  • 18. [Effect of hemodilution on systemic and capillary hematocrit].
    Jung F, Koscielny J, Mrowietz C, Wolf S, Kiesewetter H, Wenzel E.
    Infusionstherapie; 1990 Oct 23; 17(5):268-75. PubMed ID: 1705247
    [Abstract] [Full Text] [Related]

  • 19. [Middle-molecular hydroxyethyl starch as a volume substitute. Its rheological effect in peripheral arterial occlusive diseases].
    Kiesewetter H, Blume J, Bulling B, Gerhards M, Jung F, Radtke H, Franke RP.
    Dtsch Med Wochenschr; 1984 Nov 30; 109(48):1844-7. PubMed ID: 6209081
    [Abstract] [Full Text] [Related]

  • 20. [Results of the Berlin HOT/UVB comparative study in patients with peripheral arterial occlusive disorders].
    Paulitschke M, Turowski A, Lerche D.
    Z Gesamte Inn Med; 1992 Apr 30; 47(4):148-53. PubMed ID: 1595300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.